Deadline Approaches for Soleno Therapeutics Class Action Lawsuit Application on May 5, 2026

Important Notice for Soleno Investors



As the clock ticks down, investors in Soleno Therapeutics, Inc. are advised of a crucial deadline regarding a class action lawsuit. The firm Kahn Swick & Foti, LLC (KSF), with noted partner and former Attorney General of Louisiana, Charles C. Foti, Jr., is urging all affected parties to act before May 5, 2026. This action is essential for those who believe they may have suffered losses due to alleged securities fraud between March 26, 2025, and November 4, 2025.

Class Action Details


The lawsuit, identified as City of Pontiac Police and Fire Retirement System v. Soleno Therapeutics, Inc., No. 26-cv-01979, alleges that Soleno and certain executives failed to disclose critical information that could impact investors' decisions. Specifically, the complaint highlights several key areas:

1. Misrepresentation: The company allegedly downplayed or mischaracterized significant safety concerns related to its only commercial product, DCCR, which is designed to address hyperphagia in individuals with Prader-Willi syndrome (PWS).
2. Safety Risks: Evidence suggests that the treatment posed more severe health risks than publicly acknowledged, including alarming signs of excessive fluid retention among participants in clinical trials.
3. Commercial Viability: As a result of these undisclosed risks, DCCR may face challenges regarding its acceptance, patient adoption, and potential regulatory hurdles post-launch.

These assertions raise serious questions about corporate transparency and investor protection. KSF is hopeful that they can recover losses for those who've been affected.

What Should Investors Do?


If you invested in Soleno Therapeutics during the specified time and believe you suffered financial losses, now is the time to take action. KSF advises potential class members to contact them toll-free at 1-877-515-1850 or email them at [email protected] for further guidance. Even if you are not interested in being the lead plaintiff, participating in the case could still secure you some recovery.

Access More Information


For detailed information and to learn about the ongoing developments regarding this lawsuit, visit Kahn Swick & Foti Website.

About Kahn Swick & Foti, LLC


KSF is renowned for its expertise in representing investors who have experienced loss due to corporate fraud and malpractice. Ranking among the top litigation firms in the United States based on settlement value, KSF caters to both institutional and retail investors. Their offices span major locations including New York, California, and Louisiana, showcasing their expansive reach and influence in the securities litigation landscape.

For the latest updates, make sure to follow KSF on their various platforms, including Facebook, Instagram, and LinkedIn, or visit their official website.

As the deadline approaches, it’s imperative for investors to consider their options and stay informed on their rights and potential avenues for recovery. Don’t wait until it’s too late; act now to safeguard your financial interests.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.